Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SEATTLE, WA--(Marketwired - Apr 2, 2014) - Atossa Genetics, Inc. (NASDAQ: ATOS) announced today that Ben R. Chen has joined the Company as Senior Vice President of Global Regulatory Affairs and...
-
SEATTLE, WA--(Marketwired - Mar 27, 2014) - Atossa Genetics, Inc. (NASDAQ: ATOS) today announced 2013 financial results and provided an update on recent corporate developments. "With...
-
SEATTLE, WA--(Marketwired - Mar 24, 2014) - Atossa Genetics, Inc. (NASDAQ: ATOS) today announced that it will issue financial results and corporate developments for the fiscal year ended December...
-
SEATTLE, WA--(Marketwired - Mar 4, 2014) - Atossa Genetics Inc. (NASDAQ: ATOS) announced today that it has received a request for additional information from the U.S. Food and Drug Administration...
-
SEATTLE, WA--(Marketwired - Mar 3, 2014) - Atossa Genetics Inc. (NASDAQ: ATOS), announced today that Richard I. Steinhart has joined the Company's Board of Directors and has been appointed a Member...
-
SEATTLE, WA--(Marketwired - Jan 29, 2014) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced that it has closed a public offering of 5,834,234 units at a price to the public of $2.40 per...
-
SEATTLE, WA--(Marketwired - Jan 24, 2014) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced that it has priced a public offering of approximately 5.8 million units at a price to the public of...
-
SEATTLE, WA--(Marketwired - Jan 23, 2014) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced that it intends to offer units consisting of shares of common stock and warrants in a public...
-
SEATTLE, WA--(Marketwired - Jan 9, 2014) - Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company™, today announced that management will present at two upcoming investor conferences:...
-
SEATTLE, WA--(Marketwired - Dec 24, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company™, today announced that it has submitted a Premarket 510(k) Notification with the...